Early-pregnancy HDL-related inflammatory indices and risk of preeclampsia: A retrospective cohort study
PLOS One · 2025
DOI: 10.1371/journal.pone.0339322 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS One, 2025. Verfasst von Hui Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Huidong County Maternal and Child Health Hospital, Sichuang, China. Hauptthemen laut MEDLINE: Pre-Eclampsia, Lipoproteins, HDL, Inflammation. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Preeclampsia (PE) is closely associated with dyslipidemia and inflammatory imbalance. High-density lipoprotein (HDL)-related inflammatory indices have demonstrated predictive potential in cardiovascular and metabolic diseases, but evidence regarding their role in PE remains limited.
Objective
This study aimed to investigate the associations between early-pregnancy HDL-related inflammatory indices, including the lymphocyte-to-HDL ratio (LHR), monocyte-to-HDL ratio (MHR), neutrophil-to-HDL ratio (NHR), and platelet-to-HDL ratio (PHR), and the risk of PE.
Methods
A total of 5,959 women with singleton pregnancies were retrospectively included. All participants underwent complete blood counts (CBC) and lipid profiling at 11–13 weeks of gestation, from which HDL-related inflammatory indices were calculated. Associations between these indices and PE risk were systematically evaluated using modified Poisson regression, restricted cubic splines (RCS), subgroup analyses, and sensitivity analyses. To assess their potential clinical utility, prediction models incorporating HDL-related inflammatory indices were developed and evaluated using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA).
Results
Among 5,959 participants, 124 (2.08%) developed PE. Multivariable-adjusted analyses revealed that higher levels of LHR (RR = 1.99, 95% CI: 1.17–3.42, P = 0.012), MHR (RR = 2.62, 95% CI: 1.58–4.35, P < 0.001), NHR (RR = 2.87, 95% CI: 1.64–5.02, P < 0.001), and PHR (RR = 2.57, 95% CI: 1.48–4.48, P < 0.001) were significantly associated with increased PE risk. Quartile analyses demonstrated a dose-response relationship across categories ( P for trend < 0.05). RCS revealed U-shaped associations for LHR ( P = 0.008) and NHR ( P = 0.048), which became approximately linear after excluding extreme values. Subgroup analyses suggested stronger associations in women with gestational diabetes mellitus (GDM), advanced maternal age, or higher BMI, indicating potential effect modification. Sensitivity analyses confirmed the consistency of these associations. Incorporation of these indices modestly improved model discrimination (AUC 0.697) and provided limited clinical benefit in DCA.
Conclusions
Early-pregnancy HDL-related inflammatory indices, particularly MHR, NHR, and PHR, are significantly associated with increased PE risk. These indices reflect both lipid metabolism and inflammatory status, offering simple, accessible biomarkers for early risk stratification and potential supplementation of existing PE prediction strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Huidong County Maternal and Child Health Hospital, Sichuang, China.
ORCID-Profile: Hui Zhang
Zitieren
APA
Zhang, H., Bao, J. L., Li, Q. N., Xiao, K. D., & Peng, J. Q. (2025). Early-pregnancy HDL-related inflammatory indices and risk of preeclampsia: A retrospective cohort study. PLOS One. https://doi.org/10.1371/journal.pone.0339322
Vancouver
Zhang H, Bao JL, Li QN, Xiao KD, Peng JQ. Early-pregnancy HDL-related inflammatory indices and risk of preeclampsia: A retrospective cohort study. PLOS One. 2025. doi:10.1371/journal.pone.0339322
BibTeX
@article{Zhang2025,
author = {Zhang, Hui and Bao, Jin-Lan and Li, Qian-Nan and Xiao, Kun-Duo and Peng, Jin-Qiu},
title = {Early-pregnancy HDL-related inflammatory indices and risk of preeclampsia: A retrospective cohort study},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0339322}
}
EUVIMED